Hepatitis B virus infects hepatic stellate cells and affects their proliferation and expression of collagen type I

Chinese Medical Journal

Volumn 122, Issue 12, 2009, Pages 1455-1461

  Liu, Xuan ^a   Zhu, Sheng Tao ^a   You, Hong ^a   Cong, Min ^a   Liu, Tian Hui ^a   Wang, Bao En ^a   Jia, Ji Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Fibrosis; Hepatic stellate cells; Hepatitis B virus

Indexed keywords

COLLAGEN TYPE 1; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; VIRUS DNA;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION;

CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; HEPATITIS B VIRUS; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 68249150529     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.12.019     Document Type: Article

References (28)

1. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006; 101: 1-6.
2. Ljumovic D, Diamantis I, Alegakis AK, Kouroumalis EA. Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases. Clin Chim Acta 2004; 349: 203-211.
3. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003; 38: 257-265.
4. Eng FJ, Friedman SL, Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol 2000; 279: G7-G11.
5. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250.
6. Mazzocca A, Sciammetta SC, Carloni V, Cosmi L, Annunziato F, Harada T, et al. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J Biol Chem 2005; 280: 11329-11339.
7. Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, et al. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 2005; 37: 138-145.
8. Norton PA, Reis HM, Prince S, Larkin J, Pan J, Liu J, et al. Activation of fibronectin gene expression by hepatitis B virus x antigen. J Viral Hepat 2004; 11: 332-341.
9. Guo GH, Tan DM, Zhu PA, Liu F. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2. Hepatobiliary Pancreat Dis Int 2009; 8: 59-64.
10. Martín-Vílchez S, Sanz-Cameno P, Rodríguez-Muñoz Y, Majano PL, Molina-Jiménez F, López-Cabrera M, et al. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 2008; 47: 1872-1883.
11. Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15: E25-E30.
12. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-1531.
13. Huang YQ, Wang LW, Yan SN, Gong ZJ. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. Hepatobiliary Pancreat Dis Int 2004; 3: 543-547.
14. Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grün S, et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 2005; 129: 234-245.
15. Argnani R, Boccafogli L, Marconi PC, Manservigi R. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide. Gene Ther 2004; 11: 1087-1098.
16. Greupink R, Bakker HI, Bouma W, Reker-Smit C, Meijer DK, Beljaars L, et al. The antiproliferative drug Doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo. J Pharmacol Exp Ther 2006; 317: 514-521.
17. Galun E, Offensperger WB, von Weizsacker F, Offensperger S, Wands JR, Blum HE. Human non-hepatocytes support hepadnaviral replication and virion production. J Gen Virol 1992; 73: 173-178.
18. Delladetsima JK, Vafiadis I, Tassopoulos NC, Kyriakou V, Apostolaki A, Smyrnoff T. HBcAg and HBsAg expression in ductular cells in chronic hepatitis B. Liver 1994; 14: 71-75.
19. Wang RY, Shen CN, Lin MH, Tosh D, Shih C. Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus. J Virol 2005; 79: 13116-13128.
20. Rong QF, Huang J, Su EB, Li J, Li JY, Zhang LL, et al. Endothelial progenitor cell mediates transport of hepatitis B. Chin Med J 2008; 121: 248-256.
21. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, et al. HBV NAT positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005; 88: 77-86.
22. Kim TH, Cho EY, Oh HJ, Choi CS, Kim JW, Moon HB, et al. The degrees of hepatocyte cytoplasmic expression of hepatitis B core antigen correlate with histologic activity of liver disease in the young patients with chronic hepatitis B infection. J Korean Med Sci 2006; 21: 279-283.
23. Kasprzak A, Biczysko W, Adamek A, Zabel M. Morphological lesions detected by light and electron microscopies in chronic type B hepatitis. Pol J Pathol 2002; 53: 103-115.
24. Glebe D. Attachment sites and neutralising epitopes of hepatitis B virus. Minerva Gastroenterol Dietol 2006; 52: 3-21.
25. Guha C, Mohan S, Roy-Chowdhury N, Roy-Chowdhury J. Cell culture and animal models of viral hepatitis. Part I: hepatitis B. Lab Anim 2004; 33: 37-46.
26. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6: 973-985.
27. Chen DY, Ramig RF. Determinants of rotavirus stability and density during CsCl purification. Virology 1992; 186: 228-237.
28. Guettouche T, Hnatyszyn HJ. Chronic hepatitis B and viral genotype: the clinical significance of determining HBV genotypes. Antivir Ther 2005; 10: 593-604.